Switch on the healing
This article was originally published in Scrip
Action Potential Venture Capital has a lot going for it. It's a great name for a corporate venture vehicle that wants to catalyze early stage projects in neural stimulation. And it has £50m from GlaxoSmithKline to provide financial stimulation.